Adamis Pharmaceuticals Co...

NASDAQ: ADMP · Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 9:59 PM

Adamis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-26.48M -45.83M
Depreciation & Amortization
1.48M 1.44M
Stock-Based Compensation
-340.27K 1.98M
Other Working Capital
-4.22M -11.9M
Other Non-Cash Items
775.36K 6.21M
Deferred Income Tax
n/a 9.21M
Change in Working Capital
-1.34M -10.8M
Operating Cash Flow
-25.9M -37.79M
Capital Expenditures
-680.42K -1.22M
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
4.16M 1.51M
Investing Cash Flow
3.48M 282.74K
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
285M 53.94M
Financial Cash Flow
285K 53.94M
Net Cash Flow
-22.14M 16.5M
Free Cash Flow
-26.58M -39.01M